Skip to main content
. Author manuscript; available in PMC: 2022 Jul 12.
Published in final edited form as: J Acquir Immune Defic Syndr. 2021 Apr 1;86(4):422–429. doi: 10.1097/QAI.0000000000002571

Table 1.

Descriptive Statistics of the Sample, Overall and by Anticipated Future PrEP Use (N=211)

Future PrEP
Overall Sample Not Likely
(n=135; 64%)
Likely
(n=76; 36%)

N (%) or
Mean (SD)
N (%) or
Mean (SD)
N (%) or
Mean (SD)
p-value

Outcome: Anticipated PrEP Use
  Not at all likely 105 (49.8%) 135 (100.0%) -
  Somewhat unlikely 12 (5.7%)
  Not likely or unlikely 18 (8.5%)
  Somewhat likely 46 (21.8%) 76 (100.0%)
  Very Likely 30 (14.2%)
Demographics
Women (including four transwomen) 159 (75.4%) 99 (73.3%) 60 (79.0%) .36
Age (mean (SD)) 37.2 (13.2) 37.0 (13.6) 37.5 (12.4) .77
Black/African American (BAA) 126 (59.7%) 79 (58.5%) 47 (61.8%) .64
Hispanic/Latinx 51 (24.2%) 35 (25.9%) 16 (21.1%) .43
Homeless (past 6m) 107 (50.7%) 61 (45.2%) 46 (60.5%) <.05*
Arrested (ever) 157 (74.4%) 93 (68.9%) 64 (84.2%) <.05*
Discrimination (MDSR; mean (SD); range 0–10) 2.6 (2.4) 2.4 (2.2) 3.0 (2.6) <.05*
Childhood physical abuse (missing=9) 94 (46.5%) 60 (46.9%) 34 (46.0%) .90
Childhood sexual abuse (missing=10) 98 (48.8%) 63 (48.5%) 35 (49.3%) .91
Ever been forced to have sex (missing=7) 92 (45.1%) 51 (38.6%) 41 (56.9%) <.05*
PrEP & HIV Testing
Are you now or have you ever taken PrEP?
  Yes, I am currently taking it 0 (0.0%) 0 (0.0%) 0 (0.0%) .47
  Yes, I have taken it in the past 1 (0.5%) 0 (0.0%) 1 (0.5%)
  No, never taken it 81 (38.4%) 53 (39.3%) 28 (36.8%)
  I’ve never heard of it 129 (61.1%) 82 (60.7%) 47 (61.8%)
Perceived risk of HIV (mean (SD); missing=1; range 0–4) 1.0 (1.0) 0.8 (0.9) 1.4 (1.2) <.0001***
Barriers to HIV testing (mean (SD); range 1–4.9) 2.8 (0.7) 2.6 (0.7) 3.0 (0.8) <.001**
Ever previously tested for HIV (missing=1) 172 (81.9%) 108 (80.0%) 64 (85.3%) .34
Likely to test for HIV in the future (missing=2) 119 (56.9%) 65 (48.5%) 54 (72.0%) <.001**
Risk Behaviors
Consumed alcohol (past 6m; missing=5) 172 (83.5%) 106 (79.7%) 66 (90.4%) <.05*
Non-injection drug use (past 6m) 146 (69.2%) 92 (68.2%) 54 (71.1%) .66
Injection drug use (past 6m) 39 (18.5%) 22 (16.3%) 17 (22.4%) .28
Receptive syringe/paraph. sharing (past 6m; missing=5) 22 (10.7%) 12 (9.1%) 10 (13.5%) .32
Drug detoxification or treatment (ever; missing=1) 78 (37.1%) 45 (33.6%) 33 (43.4%) .16
12-step participation such as AA or NA (ever) 99 (46.9%) 54 (40.0%) 45 (59.2%) <.05*
Casual sex partner (past 6m; missing=11) 95 (47.5%) 52 (40.9%) 43 (58.9%) <.05*
Regular sex partner (past 6m; missing=11) 157 (78.5%) 101 (79.5%) 56 (76.7%) .64
High risk sex partner (past 6m; missing=22) 71 (37.6%) 41 (33.3%) 30 (45.5%) .10
Unprotected sex (past 6m) 155 (73.5%) 92 (68.2%) 63 (82.9%) <.05*
Social Network Characteristics
Size (mean (SD)) 14.3 (6.1) 14.8 (6.1) 13.5 (6.1) .13
Density (mean (SD)) 0.4 (0.3) 0.4 (0.3) 0.4 (0.3) .98
Prop. family (mean (SD)) 0.3 (0.3) 0.3 (0.3) 0.4 (0.3) <.05*
Prop. friend (mean (SD); missing=2) 0.7 (0.3) 0.7 (0.3) 0.6 (0.4) <.05*
Prop. female (mean (SD); missing=2) 0.5 (0.2) 0.5 (0.2) 0.5 (0.2) .09
Prop. taking PrEP (mean (SD); missing=1) 0.0 (0.0) 0.0 (0.0) 0.0 (0.01) .32
Prop. regularly tests for HIV (mean (SD); missing=2) 0.2 (0.3) 0.1 (0.3) 0.2 (0.4) .08
Prop. supportive of ego HIV testing (mean (SD); missing=2) 0.8 (0.4) 0.8 (0.4) 0.9 (0.3) .71

p-values derived from chi-square test and Fisher’s exact test for categorical variables and t-tests for ordinal and continuous variables

Cronbach’s alpha for scales in the current study are as follows: MDSR α=.79; Barriers to HIV testing α=.80